russjcardiolРоссийский кардиологический журналRussian Journal of Cardiology1560-40712618-7620«SILICEA-POLIGRAF» LLCrussjcardiol-1857Research ArticleПЕДИАТРИЯPEDIATRICSОСОБЕННОСТИ СПЕКТРА ЛИПОПРОТЕИДОВ У ДЕВОЧЕК С БЕССИМПТОМНОЙ ГИПЕРУРИКЕМИЕЙLipoprotein profile in girls with asymptomatic hyperuricemiaМалявскаяС. И.MaljavskayaS. I.ТоропыгинаТ. А.ToropyginaT. A.ТрильВ. Е.TrilV. E.ТерновскаяВ. А.TernovskayaV. A.Северный государственный медицинский университетRussian Federation200428022004013337Copyright © Малявская С.И., Торопыгина Т.А., Триль В.Е., Терновская В.А., 20042004Малявская С.И., Торопыгина Т.А., Триль В.Е., Терновская В.А.Maljavskaya S.I., Toropygina T.A., Tril V.E., Ternovskaya V.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://russjcardiol.elpub.ru/jour/article/view/1857хроническая бессимптомная гиперурикемияспектр липопротеидоватерогенный фенотиппрофилактика атеросклерозаподростковый возрастchronic asymptomatic hyperuricemialiporotein profileatherogenic phenotypeatherosclerosis preventionadolescenceReferencesГланс С. Медико-биологическая статистика (пер. с англ.). М.: Прогресс, 1999. 460 с.Гланс С. Медико-биологическая статистика (пер. с англ.). М.: Прогресс, 1999. 460 с.Agudelo C.A., Wise C.M. Gout: diagnosis, pathogenesis, and clinical manifestations. Curr. Opin. Rheumatol. 2001; 13 (3): 234-239.Agudelo C.A., Wise C.M. Gout: diagnosis, pathogenesis, and clinical manifestations. Curr. Opin. Rheumatol. 2001; 13 (3): 234-239.Clausen J., Borch-Johnsen K., Ibsen H. Analysis of the relationship between fasting serum uric acid and the insulin sensitivity index in a population-based sample of 380 young healthy Caucasians. Eur. J. Endocrinol. 1998; 138 (1): 63-9.Clausen J., Borch-Johnsen K., Ibsen H. Analysis of the relationship between fasting serum uric acid and the insulin sensitivity index in a population-based sample of 380 young healthy Caucasians. Eur. J. Endocrinol. 1998; 138 (1): 63-9.Culleton B.F., Larson M.G., Kannel W.B., et al. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann. Intern. Med. 1999 Jul. 6; 131(1): 7-13.Culleton B.F., Larson M.G., Kannel W.B., et al. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann. Intern. Med. 1999 Jul. 6; 131(1): 7-13.Iwatani M., Wasada Т., Iwamoto Y., et al. Insulin sensitizer and urate metabolism. Nippon. Rinsho. 2000 Feb; 58(2): 430-495.Iwatani M., Wasada Т., Iwamoto Y., et al. Insulin sensitizer and urate metabolism. Nippon. Rinsho. 2000 Feb; 58(2): 430-495.Johnson R.J., Tuttle K.R., Culleton B., et al. Much to do about nothing, or much to do about something? The continuing controversy over the role of uric acid in cardiovascular disease. Hypertension. 2000; 35: 310-312.Johnson R.J., Tuttle K.R., Culleton B., et al. Much to do about nothing, or much to do about something? The continuing controversy over the role of uric acid in cardiovascular disease. Hypertension. 2000; 35: 310-312.Leyva F., Anker S., Swan J.W., et al. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur. Heart. J. 1997 May; 18(5): 858-65.Leyva F., Anker S., Swan J.W., et al. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur. Heart. J. 1997 May; 18(5): 858-65.Leyva F., Wingrove C.S., Godsland I.F., et al. The glycolytic pathway to coronary heart disease: a hypothesis. Metabolism. 1998 Jun; 47(6): 657-62.Leyva F., Wingrove C.S., Godsland I.F., et al. The glycolytic pathway to coronary heart disease: a hypothesis. Metabolism. 1998 Jun; 47(6): 657-62.Nieto F.J., Iribarren C., Gross M.D., et al. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis, 2000. Jan; 148(1): 131-9.Nieto F.J., Iribarren C., Gross M.D., et al. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis, 2000. Jan; 148(1): 131-9.Reaven G.M. The kidney: an unwilling accomplice in syndrome X. Am. J. Kidney Dis. 1997 Dec; 30(6): 928-31.Reaven G.M. The kidney: an unwilling accomplice in syndrome X. Am. J. Kidney Dis. 1997 Dec; 30(6): 928-31.Staub M. Uric acid as a scavenger in oxidative stress. Orv. Hetil. 1999 Feb. 7; 140(6): 275-9.Staub M. Uric acid as a scavenger in oxidative stress. Orv. Hetil. 1999 Feb. 7; 140(6): 275-9.Takahashi S., Yamamoto T., Tsutsumi Z., et al. Increased visceral fat accumulation in patients with primary gout. Adv. Exp. Med. Biol. 2000; 486: 131-4.Takahashi S., Yamamoto T., Tsutsumi Z., et al. Increased visceral fat accumulation in patients with primary gout. Adv. Exp. Med. Biol. 2000; 486: 131-4.
The authors declare that there are no conflicts of interest present.